Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Protagonist Therapeutics Inc | PTGX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 25.70 | 07:00:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 25.70 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 13.72 - 33.34 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 25.70 | USD |
Protagonist Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.5B | 58.27M | - | 60M | -78.96M | -1.35 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Protagonist Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PTGX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 25.34 | 27.78 | 24.79 | 25.92 | 369,730 | 0.36 | 1.42% |
| 1 Month | 28.42 | 29.27 | 24.79 | 27.43 | 548,903 | -2.72 | -9.57% |
| 3 Months | 26.60 | 33.34 | 24.79 | 28.27 | 659,565 | -0.90 | -3.38% |
| 6 Months | 13.97 | 33.34 | 13.72 | 23.97 | 702,858 | 11.73 | 83.97% |
| 1 Year | 23.77 | 33.34 | 13.72 | 23.06 | 806,675 | 1.93 | 8.12% |
| 3 Years | 29.56 | 50.54 | 6.91 | 21.02 | 975,341 | -3.86 | -13.06% |
| 5 Years | 9.75 | 50.54 | 4.47 | 19.77 | 755,334 | 15.95 | 163.59% |
Protagonist Therapeutics Description
| Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidate to address medical needs. The Company operates and manages its business as one operating segment. |
